AGRX - Agile Therapeutics Inc. (AGRX) CEO Al Altomari on Q1 2022 Results - Earnings Call Transcript

Agile Therapeutics, Inc. (AGRX) Q1 2022 Results Conference Call May 12, 2022 4:30 PM ET Company Participants Matt Riley - Head, IR Al Altomari - Chairman, CEO Dennis Reilly - CFO Conference Call Participants Oren Livnat - H.C. Wainwright Presentation Operator Good afternoon, and welcome to the Agile Therapeutics’ First Quarter 2022 Financial Results Conference Call. Please note, today's event is being recorded. I would now like to turn the conference over to Matt Riley, Head of Investors Relations. Matt Riley Hello, everyone. And welcome to today’s conference call to discuss our first quarter 2022 financial results and corporate update. Before we start, let me remind you that today’s call will include forward-looking statements based on current expectations, including statements concerning our financial outlook and financial prospects for the future. Our outlook for the second quarter of 2022, management’s expectations for our future financial and operational performance, including our expectation

For further details see:

Agile Therapeutics, Inc. (AGRX) CEO Al Altomari on Q1 2022 Results - Earnings Call Transcript